Status:
COMPLETED
Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US
Lead Sponsor:
PATH
Collaborating Sponsors:
Fred Hutchinson Cancer Center
Conditions:
G6PD Deficiency
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The primary objective of this study is to assess the accuracy of the SD Biosensor STANDARD G6PD Analyzer in measuring G6PD activity when used by trained health care workers.
Detailed Description
This is a cross-sectional diagnostic accuracy study with up to 250 participants with a goal of obtaining 20 deficient and 20 intermediate samples. The clinic will recruit and consent study participant...
Eligibility Criteria
Inclusion
- Willingness to provide consent
Exclusion
- Blood transfusion in the past 90 days by self-report
Key Trial Info
Start Date :
May 13 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 19 2019
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04010695
Start Date
May 13 2019
End Date
September 19 2019
Last Update
May 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fred Hutchison Prevention Center
Seattle, Washington, United States, 98109